Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer

NCT07581795 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Advanced HER2-positive Breast Cancer

Interventions

DRUG: Paclitaxel polymer micelles combined with trastuzumab, pertuzumab, and adrelumab
DRUG: Taxanes combined with trastuzumab and pertuzumab.

Sponsor

Fudan University

Collaborators

[object Object]
[object Object]
[object Object]